Recursion Pharmaceuticals Inc (RXRX) is predicted to post EPS of -0.41 in the upcoming quarter : This Stock is Ticking Every Box for Top Investors
As on Thursday, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) started slowly as it slid -7.79% to $6.98, before settling in for the price of $7.57 at